Loss of Arnt (Hif1β) in mouse epidermis triggers dermal angiogenesis, blood vessel dilation and clotting defects

Laboratory Investigation

Volumn 92, Issue 1, 2012, Pages 110-124

  Wondimu, Assefa ^a,c   Weir, Lynda ^b   Robertson, Douglas ^b   Mezentsev, Alexandre ^a   Kalachikov, Sergey ^a   Panteleyev, Andrey A ^a,b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

^c CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

Arnt2; Egln3 Phd3; Hif1a; keratinocytes; S100a genes; vasculature; von Willebrand factor

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1BETA; VON WILLEBRAND FACTOR;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD CLOTTING DISORDER; CONTROLLED STUDY; ENVIRONMENTAL STRESS; EPIDERMIS; FEMALE; MOUSE; NONHUMAN; PARACRINE SIGNALING; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEPLETION; SKIN BLOOD VESSEL; VASODILATATION;

ANIMALS; ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BLOOD COAGULATION DISORDERS; CELL NUCLEUS; CELLS, CULTURED; EPIDERMIS; KERATINOCYTES; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PHYSIOLOGIC; PROCOLLAGEN-PROLINE DIOXYGENASE; PROTEIN MULTIMERIZATION; SIGNAL TRANSDUCTION; SKIN; VASODILATION; VON WILLEBRAND FACTOR;

EID: 84855225086     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2011.134     Document Type: Article

References (104)

1. Detmar M. Tumor angiogenesis. J Invest Dermatol Symp Proc 2000;5: 20-23. (Pubitemid 32044085)
2. Mecklenburg L, Tobin DJ, Muller-Rover S, et al. Active hair growth (anagen) is associated with angiogenesis. J Invest Dermatol 2000; 114:909-916. (Pubitemid 30252710)
3. Bhushan M, Young HS, Brenchley PE, et al. Recent advances in cutaneous angiogenesis. Br J Dermatol 2002;147:418-425. (Pubitemid 35015272)
4. Rosenberger C, Solovan C, Rosenberger AD, et al. Upregulation of hypoxia-inducible factors in normal and psoriatic skin. J Invest Dermatol 2007;127:2445-2452. (Pubitemid 47619751)
5. Chang E, Yang J, Nagavarapu U, et al. Aging and survival of cutaneous microvasculature. J Invest Dermatol 2002;118:752-758. (Pubitemid 34526536)
6. Li L, Mac-Mary S, Sainthillier JM, et al. Age-related changes of the cutaneous microcirculation in vivo. Gerontology 2006;52: 142-153. (Pubitemid 43800676)
7. Detmar M. The role of VEGF and thrombospondins in skin angiogenesis. J Dermatol Sci 2000;24(Suppl 1):S78-S84. (Pubitemid 32008465)
8. Wong BJ, Minson CT. Neurokinin-1 receptor desensitization attenuates cutaneous active vasodilatation in humans. J Physiol 2006;577:1043-1051. (Pubitemid 44882611)
9. Yano K, Kadoya K, Kajiya K, et al. Ultraviolet B irradiation of human skin induces an angiogenic switch that is mediated by upregulation of vascular endothelial growth factor and by downregulation of thrombospondin-1. Br J Dermatol 2005;152:115-121.
10. Boutin AT, Weidemann A, Fu Z, et al. Epidermal sensing of oxygen is essential for systemic hypoxic response. Cell 2008;133:223-234. (Pubitemid 351508305)
11. Barnhill RL, Parkinson EK, Ryan TJ. Supernatants from cultured human epidermal keratinocytes stimulate angiogenesis. Br J Dermatol 1984;110:273-281. (Pubitemid 14155644)
12. Malhotra R, Stenn KS, Fernandez LA, et al. Angiogenic properties of normal and psoriatic skin associate with epidermis, not dermis. Lab Invest 1989;61:162-165. (Pubitemid 19222745)
13. Detmar M, Brown LF, Claffey KP, et al. Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis. J Exp Med 1994;180:1141-1146. (Pubitemid 24256627)
14. Detmar M, Brown LF, Schon MP, et al. Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice. J Invest Dermatol 1998;111:1-6. (Pubitemid 28309201)
15. Elson DA, Thurston G, Huang LE, et al. Induction of hypervascularity without leakage or inflammation in transgenic mice overexpressing hypoxia-inducible factor-1alpha. Genes Dev 2001; 15:2520-2532. (Pubitemid 32937863)
16. Cockman ME, Masson N, Mole DR, et al. Hypoxia inducible factoralpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein. J Biol Chem 2000;275:25733-25741.
17. Gruber M, Simon MC. Hypoxia-inducible factors, hypoxia, and tumor angiogenesis. Curr Opin Hematol 2006;13:169-174.
18. Tanimoto K, Makino Y, Pereira T, et al. Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein. Embo J 2000;19:4298-4309. (Pubitemid 30623741)
19. Guillemin K, Krasnow MA. The hypoxic response: huffing and HIFing. Cell 1997;89:9-12. (Pubitemid 27180579)
20. Semenza GL, Wang GL. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol 1992;12:5447-5454.
21. Gu YZ, Hogenesch JB, Bradfield CA. The PAS superfamily: sensors of environmental and developmental signals. Annu Rev Pharmacol Toxicol 2000;40:519-561. (Pubitemid 30340692)
22. Goda N, Dozier SJ, Johnson RS. HIF-1 in cell cycle regulation, apoptosis, and tumor progression. Antioxid Redox Signal 2003;5: 467-473. (Pubitemid 37087407)
23. Wang GL, Jiang BH, Rue EA, et al. Hypoxia-inducible factor 1 is a basichelix- loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA 1995;92:5510-5514.
24. Choi SM, Oh H, Park H. Microarray analyses of hypoxia-regulated genes in an aryl hydrocarbon receptor nuclear translocator (Arnt)- dependent manner. Febs J 2008;275:5618-5634.
25. Geng S, Mezentsev A, Kalachikov S, et al. Targeted ablation of Arnt in mouse epidermis results in profound defects in desquamation and epidermal barrier function. J Cell Sci 2006;119:4901-4912. (Pubitemid 46017803)
26. Weir L, Robertson D, Leigh IM, et al. Hypoxia-mediated control of HIF/ ARNT machinery in epidermal keratinocytes. Biochim Biophys Acta 2011;1813:60-72.
27. Vasioukhin V, Degenstein L, Wise B, et al. The magical touch: genome targeting in epidermal stem cells induced by tamoxifen application to mouse skin. Proc Natl Acad Sci USA 1999;96:8551-8556. (Pubitemid 29354829)
28. Tomita S, Sinal CJ, Yim SH, et al. Conditional disruption of the aryl hydrocarbon receptor nuclear translocator (Arnt) gene leads to loss of target gene induction by the aryl hydrocarbon receptor and hypoxiainducible factor 1alpha. Mol Endocrinol 2000;14:1674-1681.
29. Maloyan A, Eli-Berchoer L, Semenza GL, et al. HIF-1alpha-targeted pathways are activated by heat acclimation and contribute to acclimation-ischemic cross-tolerance in the heart. Physiol Genomics 2005;23:79-88.
30. Banerji S, Ni J, Wang SX, et al. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol 1999;144:789-801. (Pubitemid 29234556)
31. Chilov D, Camenisch G, Kvietikova I, et al. Induction and nuclear translocation of hypoxia-inducible factor-1 (HIF-1): heterodimerization with ARNT is not necessary for nuclear accumulation of HIF-1alpha. J Cell Sci 1999;112:1203-1212. (Pubitemid 29218909)
32. Maltepe E, Schmidt JV, Baunoch D, et al. Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT. Nature 1997;386:403-407. (Pubitemid 27154481)
33. Kozak KR, Abbott B, Hankinson O. ARNT-deficient mice and placental differentiation. Dev Biol 1997;191:297-305. (Pubitemid 28282914)
34. Walisser JA, Bunger MK, Glover E, et al. Patent ductus venosus and dioxin resistance in mice harboring a hypomorphic Arnt allele. J Biol Chem 2004;279:16326-16331.
35. Fandrey J, Gorr TA, Gassmann M. Regulating cellular oxygen sensing by hydroxylation. Cardiovasc Res 2006;71:642-651. (Pubitemid 44848002)
36. Oehme F, Ellinghaus P, Kolkhof P, et al. Overexpression of PH-4, a novel putative proline 4-hydroxylase, modulates activity of hypoxiainducible transcription factors. Biochem Biophys Res Commun 2002; 296:343-349.
37. Nakayama K, Frew IJ, Hagensen M, et al. Siah2 regulates stability of prolyl-hydroxylases, controls HIF1alpha abundance, and modulates physiological responses to hypoxia. Cell 2004;117:941-952. (Pubitemid 38798859)
38. Takeda K, Cowan A, Fong GH. Essential role for prolyl hydroxylase domain protein 2 in oxygen homeostasis of the adult vascular system. Circulation 2007;116:774-781. (Pubitemid 47255995)
39. Ema M, Taya S, Yokotani N, et al. A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1a regulates the VEGF expression and is potentially involved in lung and vascular development. Proc Natl Acad Sci USA 1997;94:4273-4278.
40. Takahata S, Sogawa K, Kobayashi A, et al. Transcriptionally active heterodimer formation of an Arnt-like PAS protein, Arnt3, with HIF-1a, HLF, and clock. Biochem Biophys Res Commun 1998;248: 789-794. (Pubitemid 28404501)
41. Hogenesch JB, Gu YZ, Moran SM, et al. The basic helix-loop-helix-PAS protein MOP9 is a brain-specific heterodimeric partner of circadian and hypoxia factors. J Neurosci 2000;20:RC83.
42. Sekine H, Mimura J, Yamamoto M. Unique and overlapping transcriptional roles of arylhydrocarbon receptor nuclear translocator (Arnt) and Arnt2 in xenobiotic and hypoxic responses. J Biol Chem 2006;281:37507-37516. (Pubitemid 46042054)
43. Kawara S, Mydlarski R, Mamelak AJ, et al. Low-dose ultraviolet B rays alter the mRNA expression of the circadian clock genes in cultured human keratinocytes. J Invest Dermatol 2002;119:1220-1223. (Pubitemid 36005601)
44. Bjarnason GA, Jordan RC, Wood PA, et al. Circadian expression of clock genes in human oral mucosa and skin: association with specific cell-cycle phases. Am J Pathol 2001;158:1793-1801. (Pubitemid 32422944)
45. Schoenhard JA, Smith LH, Painter CA, et al. Regulation of the PAI-1 promoter by circadian clock components: differential activation by BMAL1 and BMAL2. J Mol Cell Cardiol 2003;35:473-481. (Pubitemid 36539453)
46. Semenza GL. Hypoxia-inducible factor 1 and the molecular physiology of oxygen homeostasis. J Lab Clin Med 1998;131:207-214. (Pubitemid 28154043)
47. Blancher C, Moore JW, Talks KL, et al. Relationship of hypoxiainducible factor (HIF)-1alpha and HIF-2alpha expression to vascular endothelial growth factor induction and hypoxia survival in human breast cancer cell lines. Cancer Res 2000;60:7106-7113. (Pubitemid 32059191)
48. Kaelin Jr WG. The von Hippel-Lindau protein, HIF hydroxylation, and oxygen sensing. Biochem Biophys Res Commun 2005;338: 627-638.
49. Keith B, Adelman DM, Simon MC. Targeted mutation of the murine arylhydrocarbon receptor nuclear translocator 2 (Arnt2) gene reveals partial redundancy with Arnt. Proc Natl Acad Sci USA 2001;98: 6692-6697. (Pubitemid 32538278)
50. Hosoya T, Oda Y, Takahashi S, et al. Defective development of secretory neurones in the hypothalamus of Arnt2-knockout mice. Genes Cells 2001;6:361-374. (Pubitemid 32401281)
51. Takagi S, Tojo H, Tomita S, et al. Alteration of the 4-sphingenine scaffolds of ceramides in keratinocyte-specific Arnt-deficient mice affects skin barrier function. J Clin Invest 2003;112:1372-1382. (Pubitemid 38057691)
52. Oliver G, Alitalo K. The lymphatic vasculature: recent progress and paradigms. Annu Rev Cell Dev Biol 2005;21:457-483. (Pubitemid 41740643)
53. Wigle JT, Oliver G. Prox1 function is required for the development of the murine lymphatic system. Cell 1999;98:769-778. (Pubitemid 29446894)
54. Abtahian F, Guerriero A, Sebzda E, et al. Regulation of blood and lymphatic vascular separation by signaling proteins SLP-76 and Syk. Science 2003;299:247-251. (Pubitemid 36125210)
55. Fu J, Gerhardt H, McDaniel JM, et al. Endothelial cell O-glycan deficiency causes blood/lymphatic misconnections and consequent fatty liver disease in mice. J Clin Invest 2008;118:3725-3737.
56. Ichise H, Ichise T, Ohtani O, et al. Phospholipase Cgamma2 is necessary for separation of blood and lymphatic vasculature in mice. Development 2009;136:191-195.
57. Turner M, Mee PJ, Costello PS, et al. Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk. Nature 1995;378:298-302.
58. Cheng AM, Rowley B, Pao W, et al. Syk tyrosine kinase required for mouse viability and B-cell development. Nature 1995;378:303-306.
59. Clements JL, Lee JR, Gross B, et al. Fetal hemorrhage and platelet dysfunction in SLP-76-deficient mice. J Clin Invest 1999;103:19-25. (Pubitemid 29031159)
60. Nalbandian RM, Mader IJ, Barrett JL, et al. Petechiae, ecchymoses, and necrosis of skin induced by coumarin congeners: rare, occasionally lethal complication of anticoagulant therapy. Jama 1965;192: 603-608.
61. Croce K, Gao H, Wang Y, et al. Myeloid-related protein-8/14 is critical for the biological response to vascular injury. Circulation 2009; 120:427-436.
62. Ryckman C, Vandal K, Rouleau P, et al. Proinflammatory activities of S100: proteins S100A8, S100A9, and S100A8/A9 induce neutrophil chemotaxis and adhesion. J Immunol 2003;170:3233-3242. (Pubitemid 36302201)
63. Wedmore CV, Williams TJ. Control of vascular permeability by polymorphonuclear leukocytes in inflammation. Nature 1981;289: 646-650. (Pubitemid 11145328)
64. Thorey IS, Roth J, Regenbogen JS, et al. The Ca2+-binding proteins S100A8 and S100A9 are encoded by novel injury-regulated genes. J Biol Chem 2001;276:35818-35825.
65. Dassah M, Deora AB, He K, et al. The endothelial cell annexin A2 system and vascular fibrinolysis. Gen Physiol Biophys 2009;28:F20-F28.
66. Donato R. Intracellular and extracellular roles of S100 proteins. Microsc Res Tech 2003;60:540-551.
67. He KL, Deora AB, Xiong H, et al. Endothelial cell annexin A2 regulates polyubiquitination and degradation of its binding partner S100A10/ p11. J Biol Chem 2008;283:19192-19200.
68. Hanly AM, Hayanga A, Winter DC, et al. Thrombomodulin: tumour biology and prognostic implications. Eur J Surg Oncol 2005;31:217-220. (Pubitemid 40361508)
69. Jackson CJ, Xue M. Activated protein C - an anticoagulant that does more than stop clots. Int J Biochem Cell Biol 2008;40:2692-2697.
70. Daimon T, Nakano M. Immunohistochemical localization of thrombomodulin in the stratified epithelium of the rat is restricted to the keratinizing epidermis. Histochem Cell Biol 1999;112:437-442. (Pubitemid 30169591)
71. Artuc M, Hermes B, Algermissen B, et al. Expression of prothrombin, thrombin and its receptors in human scars. Exp Dermatol 2006;15: 523-529. (Pubitemid 43834487)
72. Balsara RD, Ploplis VA. Plasminogen activator inhibitor-1: the doubleedged sword in apoptosis. Thromb Haemost 2008;100:1029-1036.
73. Braungart E, Magdolen V, Degitz K. Retinoic acid upregulates the plasminogen activator system in human epidermal keratinocytes. J Invest Dermatol 2001;116:778-784. (Pubitemid 32467660)
74. Hecke A, Brooks H, Meryet-Figuiere M, et al. Successful silencing of plasminogen activator inhibitor-1 in human vascular endothelial cells using small interfering RNA. Thromb Haemost 2006;95:857-864.
75. Schafer K, Konstantinides S. PAI-1 and vasculopathy: the debate continues. J Thromb Haemost 2004;2:13-15 . (Pubitemid 40185613)
76. Chen X, Niyonsaba F, Ushio H, et al. Antimicrobial peptides human beta-defensin (hBD)-3 and hBD-4 activate mast cells and increase skin vascular permeability. Eur J Immunol 2007;37:434-444. (Pubitemid 46915583)
77. DiStasi MR, Ley K. Opening the flood-gates: how neutrophilendothelial interactions regulate permeability. Trends Immunol 2009;30:547-556.
78. Abdel-Malak NA, Mofarrahi M, Mayaki D, et al. Early growth response- 1 regulates angiopoietin-1-induced endothelial cell proliferation, migration, and differentiation. Arterioscler Thromb Vasc Biol 2009; 29:209-216.
79. Kase S, He S, Sonoda S, et al. alphaB-crystallin regulation of angiogenesis by modulation of VEGF. Blood 2010;115:3398-3406.
80. Miyashita H, Sato Y. Metallothionein 1 is a downstream target of vascular endothelial zinc finger 1 (VEZF1) in endothelial cells and participates in the regulation of angiogenesis. Endothelium 2005;12:163-170. (Pubitemid 41600860)
81. Guaiquil VH, Swendeman S, Zhou W, et al. ADAM8 is a negative regulator of retinal neovascularization and of the growth of heterotopically injected tumor cells in mice. J Mol Med 2010;88:497-505.
82. Nakayama K, Qi J, Ronai Z. The ubiquitin ligase Siah2 and the hypoxia response. Mol Cancer Res 2009;7:443-451.
83. Bai L, Yu Z, Qian G, et al. SOCS3 was induced by hypoxia and suppressed STAT3 phosphorylation in pulmonary arterial smooth muscle cells. Respir Physiol Neurobiol 2006;152:83-91.
84. Yang SF, Yeh YT, Wang SN, et al. SOCS-3 is associated with vascular invasion and overall survival in hepatocellular carcinoma. Pathology 2008;40:558-563.
85. Braverman IM, Keh A, Jacobson BS. Ultrastructure and threedimensional organization of the telangiectases of hereditary hemorrhagic telangiectasia. J Invest Dermatol 1990;95:422-427. (Pubitemid 20331987)
86. Mezzano D, Quiroga T, Pereira J. The level of laboratory testing required for diagnosis or exclusion of a platelet function disorder using platelet aggregation and secretion assays. Semin Thromb Hemost 2009;35:242-254.
87. Weiss HJ, Sussman II, Hoyer LW. Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand's disease. J Clin Invest 1977;60:390-404. (Pubitemid 8154146)
88. Denis C, Methia N, Frenette PS, et al. A mouse model of severe von Willebrand disease: defects in hemostasis and thrombosis. Proc Natl Acad Sci USA 1998;95:9524-9529. (Pubitemid 28506264)
89. Takuwa Y, Takuwa N, Sugimoto N. The Edg family G protein-coupled receptors for lysophospholipids: their signaling properties and biological activities. J Biochem 2002;131:767-771. (Pubitemid 34717578)
90. Yonesu K, Kawase Y, Inoue T, et al. Involvement of sphingosine-1- phosphate and S1P1 in angiogenesis: analyses using a new S1P1 antagonist of non-sphingosine-1-phosphate analog. Biochem Pharmacol 2009;77:1011-1020.
91. Denko N, Schindler C, Koong A, et al. Epigenetic regulation of gene expression in cervical cancer cells by the tumor microenvironment. Clin Cancer Res 2000;6:480-487. (Pubitemid 30111467)
92. Wahl AS, Buchthal B, Rode F, et al. Hypoxic/ischemic conditions induce expression of the putative pro-death gene Clca1 via activation of extrasynaptic N-methyl-D-aspartate receptors. Neuroscience 2009;158:344-352.
93. Jian B, Wang D, Chen D, et al. Hypoxia-induced alteration of mitochondrial genes in cardiomyocytes. role of Bnip3 and Pdk1. Shock 2010;34:169-175.
94. Schober A, Zernecke A. Chemokines in vascular remodeling. Thromb Haemost 2007;97:730-737. (Pubitemid 46779958)
95. Essafi-Benkhadir K, Onesto C, Stebe E, et al. Tristetraprolin inhibits Ras-dependent tumor vascularization by inducing vascular endothelial growth factor mRNA degradation. Mol Biol Cell 2007;18: 4648-4658. (Pubitemid 350060189)
96. Kim TW, Yim S, Choi BJ, et al. Tristetraprolin regulates the stability of HIF-1alpha mRNA during prolonged hypoxia. Biochem Biophys Res Commun 2010;391:963-968.
97. Van de Wouwer M, Collen D, Conway EM. Thrombomodulin-protein C-EPCR system: integrated to regulate coagulation and inflammation. Arterioscler Thromb Vasc Biol 2004;24:1374-1383. (Pubitemid 39050428)
98. Yan SF, Fujita T, Lu J, et al. Egr-1, a master switch coordinating upregulation of divergent gene families underlying ischemic stress. Nat Med 2000;6:1355-1361. (Pubitemid 32001019)
99. Liao H, Hyman MC, Lawrence DA, et al. Molecular regulation of the PAI-1 gene by hypoxia: contributions of Egr-1, HIF-1alpha, and C/EBPalpha. Faseb J 2006;21:935-949. (Pubitemid 46348266)
100. Impagnatiello MA, Weitzer S, Gannon G, et al. Mammalian sprouty-1 and -2 are membrane-anchored phosphoprotein inhibitors of growth factor signaling in endothelial cells. J Cell Biol 2001;152:1087-1098. (Pubitemid 34286083)
101. Zhang C, Chaturvedi D, Jaggar L, et al. Regulation of vascular smooth muscle cell proliferation and migration by human sprouty 2. Arterioscler Thromb Vasc Biol 2005;25:533-538. (Pubitemid 40315674)
102. Qin H, Shao Q, Thomas T, et al. Connexin26 regulates the expression of angiogenesis-related genes in human breast tumor cells by both GJIC-dependent and -independent mechanisms. Cell Commun Adhes 2003;10:387-393. (Pubitemid 38081402)
103. Raffel GD, Chu GC, Jesneck JL, et al. Ott1 (Rbm15) is essential for placental vascular branching morphogenesis and embryonic development of the heart and spleen. Mol Cell Biol 2009;29:333-341.
104. Benezra R, Rafii S, Lyden D. The Id proteins and angiogenesis. Oncogene 2001;20:8334-8341. (Pubitemid 34121904)